Press Releases

National defense takes on expanded meaning in Huntsville

BioDefense Symposium to connect local industries

Huntsville, Ala - Protecting the nation from harm is a growing pledge in Huntsville. Leaders at the HudsonAlpha Institute for Biotechnology aim to further catalyze the city’s role in fortifying safety levels for civilians and soldiers through the upcoming BioDefense Symposium.

CFDRC awarded NSF project to design and optimize algae growth systems

The National Science Foundation (NSF) awarded CFD Research Corporation (CFDRC) a competitive contract to develop high-fidelity modeling and simulation tools to design and optimize microalgae growth systems. Microalgae organisms are a renewable resource being exploited for a wide range of applications including biofuels, wastewater remediation, animal feed, and health food supplements.

Clarient announces publication of Mammostrat® breast cancer study in Breast Cancer Research

Novel breast cancer test classifies risk of recurrence of breast cancer

Aliso Viejo, CA (July 12, 2010) – Clarient, Inc. (NASDAQ: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient Insight®Dx Mammostrat®, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer-reviewed medical journal. The manuscript, currently available in provisional format at the journal website (http://breast-cancer-research.com), is titled “Mammostrat® as a Tool to Stratify Breast Cancer Patients at Risk of Recurrence during Endocrine Therapy.”

The manuscript reports the results of a 1,540-patient study, led by John Bartlett, Professor of Molecular Pathology at the University of Edinburgh in Scotland, further validating the Mammostrat test as an aid for risk-stratifying early stage hormone receptor-treated breast cancer patients. In addition, the manuscript reports for the first time that the Mammostrat test may be useful as a tool for risk-stratifying, node-positive patients and those who do not express hormone receptors.

CFDRC to demonstrate its Bio‐Battery technology at 44th Power Sources Conference

Las Vegas, Nevada, June 14‐17

Huntsville, Ala. - CFD Research Corporation (CFDRC), a high‐tech small business developing innovative  technologies for military and commercial markets, will be demonstrating its award winning Bio‐Battery  technology at the 44th Power Sources Conference in Las Vegas, Nev. The Bio‐Battery is a novel  micropower source which harvests energy from biological fuels such as sugars and converts them into  electrical energy providing a sustained, on‐demand power source. The product is adaptable for many  low power applications in both the military and commercial markets. CFDRC’s Bio‐Battery offers several  advantages over conventional fuel cells and batteries; including reduced size and weight, instant  recharge, flexible shape, renewable biocatalysts, environmental‐friendliness, room temperature  operation, and readily available fuel source.

A cell for your cell?

HudsonAlpha iCell salutes institute collaborations

Digital Radiance, one of the 13 resident companies located at the HudsonAlpha Institute for Biotechnology, announces the release of HudsonAlpha iCell, a free application now available on Apple’s App Store. Ron Phillips, president of Digital Radiance, said, “HudsonAlpha iCell is a biological cell visualization tool for the iPhone, iPod Touch, and iPad.” For the first time students and teachers can directly manipulate detailed 3-D models of a plant cell, an animal cell and a bacterial cell by touching to rotate, zoom and identify cell structures.

HudsonAlpha iCell

Education

Web-based tool gives 3-D view inside a cell

Some things are very difficult to visualize from the flat pages of a book. Among them is one of life’s basic building blocks: the cell.

HudsonAlpha partners to host gubernatorial forum

Candidates to focus on education

This coming February, HudsonAlpha, The Huntsville Times and WHNT News 19 will host a nonpartisan Gubernatorial Candidates’ Forum on the Future of Education.

Donation spurs next steps for CRP Biotech Campus

This aerial photograph shows the progress underway at the future McMillian Park.

Alpha Foundation provides $1.6 million gift to nurture research and economy

Huntsville, Ala -- With a growing roster of non-profit researchers and new tenant businesses at the HudsonAlpha Institute for Biotechnology, Lonnie McMillian, president of the Alpha Foundation, has stepped forward to ensure ongoing momentum in the development of Huntsville’s biotech sector. McMillian, who is also co-chairman of the HudsonAlpha Institute board of directors, has committed $1.6 million toward developing the green space that runs the entire length of the nearly mile-long Cummings Research Park Biotech Campus.

“Between prospects, the launch of new companies and the rapid growth of one of the HudsonAlpha tenants, it has become apparent that new construction on the campus is imminent,” said McMillian.

Boeing sponsors HudsonAlpha educator academy

GTAC will send teachers to the lab to benefit high school classrooms

Huntsville, Ala. -- HudsonAlpha and The Boeing Company know that when high school science teachers go back to the lab, the student classroom is sure to benefit.

Image: Tony Jones, vice president and Huntsville site executive for The Boeing Company, and Dr. Neil Lamb, examine fluorescent fish in the HudsonAlpha educational teaching lab.

HudsonAlpha is host site for NIH collaboration

Centers of Excellence in Genomic Sciences and Minority Action Plan meetings held

Meetings of the NHGRI-supported Centers of Excellence in Genomic Science grantees and Research Training Advisory Committee with Minority Action Plan grantees were recently held at the HudsonAlpha Institute for Biotechnology. More than 100 principal investigators and researchers from around the country converged at HudsonAlpha in mid-October to share data and collaborate on issues and concerns that ultimately impact the integration of genomics with biomedical research.

The National Human Genome Research Institute, one of the 27 institutes and centers of the National Institutes of Health, supports a broad range of projects toward increasing understanding of the structure and function of the human genome and its role in health and disease. NHGRI is also committed to increasing the number of individuals from under-represented minority groups who choose career paths in genomic research and its ethical, legal and social implications.